The Patent Finder

Merck Sante

Also on record
Records under this name other than patents Merck Sante holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Merck Sante

PatentTitleStatus Expires Confidence
US 7,034,021Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
Term ended
Term ended Oct 31, 2021 · From the USPTO record
Term endedTerm ended Oct 31, 2021From the USPTO record
US 7,767,676Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
Term ended
Term ended Oct 25, 2021 · From the USPTO record
Term endedTerm ended Oct 25, 2021From the USPTO record
US 7,452,883Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
Term ended
Ended no later than Jan 25, 2021 · From the USPTO record
Term endedEnded no later than Jan 25, 2021From the USPTO record
US 6,512,009Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator
Term ended
Term ended Jan 12, 2021 · From the USPTO record
Term endedTerm ended Jan 12, 2021From the USPTO record
US 6,265,437Aminoalkanesulphonic acid derivatives, their preparation and their use as medicaments
Term ended
Term ended Oct 12, 2020 · From the USPTO record
Term endedTerm ended Oct 12, 2020From the USPTO record
US RE38,629Solid oral dosage form comprising a combination of metformin and glibenclamide
Term ended
Term ended Jul 14, 2019 · From the USPTO record
Term endedTerm ended Jul 14, 2019From the USPTO record
US 7,651,844Method for screening agents capable of treating obesity
Lapsed on the fee record
Ended Jan 26, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jan 26, 2018From the USPTO record
US 8,119,609Methods of treating diabetic retinopathy with pericyte apoptosis inhibitors
Lapsed on the fee record
Ended Feb 21, 2016 · From the USPTO record
Lapsed on the fee recordEnded Feb 21, 2016From the USPTO record
US 6,303,146Solid oral dosage form comprising a combination of metformin and glibenclamide
Formerly held
Surrendered on reissue
Surrendered on reissue Oct 19, 2004 · From the USPTO record
Surrendered on reissueSurrendered on reissue Oct 19, 2004From the USPTO record
US 5,769,073Powder inhalator
Formerly held
Term ended
Term ended no later than Jun 23, 2018 · Low confidence
Term endedTerm ended no later than Jun 23, 2018Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited